COLEMAN KIRK ALLEN 4
4 · TFF Pharmaceuticals, Inc. · Filed Mar 17, 2021
Insider Transaction Report
Form 4
COLEMAN KIRK ALLEN
CFO, Secretary, and Treasurer
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2021-03-15−5,000→ 277,883 totalExercise: $2.50From: 2020-04-11Exp: 2029-04-11→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2021-03-15$2.50/sh+5,000$12,500→ 6,000 total - Sale
Common Stock
2021-03-15$17.05/sh−5,000$85,250→ 1,000 total
Footnotes (3)
- [F1]The transactions reported by this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020.
- [F2]The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
- [F3]37,500 shares of common stock vested on April 11, 2020 and the remainder of the shares vested at an approximate rate of 9,375 every three months thereafter.